Magolin Tablet 2.5 mg contains Mirogabalin Besylate, a neuropathic pain medication indicated for the treatment of nerve-related pain such as diabetic peripheral neuropathy (DPN) and post-herpetic neuralgia (PHN). Mirogabalin belongs to the gabapentinoid class, which works by modulating nerve signaling in the central nervous system to reduce abnormal pain sensations.

The 2.5 mg dose is typically prescribed as a starting dose to evaluate patient tolerance, especially in individuals sensitive to side effects like drowsiness or dizziness. This low-dose initiation allows gradual titration to higher doses such as 5 mg, 10 mg, or 15 mg based on clinical response and tolerability.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Magolin Tablet 2.5 mg works by targeting the α2δ-1 subunit of voltage-gated calcium channels in nerve cells:

• Reduces calcium influx into nerve terminals, limiting the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P.

• Decreases nerve hyperexcitability, thereby alleviating abnormal sensations such as burning, tingling, numbness, or shooting pain.

• Modulates central nervous system signaling, addressing the underlying cause of neuropathic pain rather than merely masking symptoms.

This mechanism provides sustained relief from chronic nerve pain while minimizing systemic side effects often seen with other analgesics.

Indications

Magolin Tablet 2.5 mg is indicated for:

• Diabetic peripheral neuropathy (DPN): Helps manage chronic nerve pain in diabetic patients.

• Post-herpetic neuralgia (PHN): Reduces persistent pain following shingles infection.

• Other neuropathic pain conditions, as determined by a healthcare professional.

It is not intended for acute pain management such as post-operative pain or trauma-related pain.

Dosage and Administration

• The recommended starting dose is 2.5 mg once daily, typically taken in the evening to minimize daytime drowsiness.

• Swallow the tablet whole with water, with or without food.

• The dose may be gradually increased to 5 mg, 10 mg, or 15 mg daily depending on efficacy and tolerability.

• Dose adjustments are necessary for patients with renal impairment, as Mirogabalin is primarily excreted via the kidneys.

• Do not abruptly discontinue the medication; sudden cessation may cause rebound pain or withdrawal symptoms.

Precautions

• Use with caution in patients with kidney dysfunction, history of dizziness, or excessive sedation.

• Avoid alcohol and CNS depressants, which may enhance drowsiness or impair coordination.

• Inform your doctor about all concurrent medications to prevent potential drug interactions, particularly with opioids, antidepressants, or anticonvulsants.

• Monitor for neuropsychiatric effects, including depression, mood changes, or suicidal thoughts, although these are rare.

• Use during pregnancy or breastfeeding only under medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Magolin Tablet 2.5 mg is generally well-tolerated. Common side effects include:

• Drowsiness or fatigue

• Dizziness or lightheadedness

• Headache

• Mild swelling of hands or feet (peripheral edema)

• Gastrointestinal discomfort such as nausea

Rare side effects may include:

• Mood or behavioral changes

• Allergic reactions such as rash, itching, or swelling

Most side effects are dose-dependent and may improve with gradual titration.

Storage

Store Magolin Tablet 2.5 mg in a cool, dry place below 30°C, protected from sunlight and moisture. Keep out of reach of children.

Magolin Tablet 2.5 mg provides initial, safe, and effective management of neuropathic pain, allowing patients to start therapy at a low dose with gradual titration for optimal pain relief and improved quality of life.